|
Download
(1004.41 KB)
|
-
Since the onset of the pandemic in 2020 and up to June 28, 2022, a cumulative total of approximately 546.9 million COVID-19 cases including about 6.3 million deaths were reported from all six WHO regions. During epidemiological week (EW) 25, cases increased in four WHO regions (range: 13.9% - 46.8%) while they decreased in two regions – the African region (-34.4%) and the Western Pacific region (-2.5%). COVID-19 deaths increased in four WHO regions (range: 2.9% - 22.1%) while they decreased in the regions of Western Pacific (-6.1%) and Europe (-1.3%).
-
Globally, approximately 4.3 million new COVID-19 cases were reported in EW 25 (June 19, 2022-June 25, 2022) - a 20.3% increase compared to EW 24 (June 12, 2022-June 18, 2022) (Figure 1). For the same period, 8,753 new COVID- 19 deaths were reported globally – a 3.4% relative increase compared to the previous week.
-
In the region of the Americas, 1,371,165 cases and 4,158 deaths were reported in EW 25 - a 13.9% increase in cases and a 9.4% increase in deaths compared to the previous week.
-
At the subregional level, COVID-19 cases increased in all subregions (range: 3.2-48.4%) and deaths increased in two subregions - South America (32.8%) and the Caribbean and Atlantic Ocean Islands (13.3%).
-
The overall weekly case notification rate for the region of the Americas was 134.1 cases per 100,000 population during EW 25 (117.7 the previous week). Between EW 25 and 24, the 14-day COVID-19 death rate was 7.8 deaths per 1 million population (7.6 the previous two weeks).
-
Among 32 countries/territories in the region with available data, COVID-19 hospitalizations increased in 13 countries and territories (range: 2.8% - 100%) during EW 25 compared to the previous week. Among 26 countries and territories with available data, COVID-19 ICU admissions increased in 9 countries and territories (range: 2.3% - 100%).
-
The global increase in the prevalence of Omicron lineages BA.4 and BA.5 has coincided with a rise in COVID-19 incidence for many countries and territories including those in the region of the Americas. For some countries and territories, a subsequent rise in hospitalizations and ICU was also observed – however current evidence available does not indicate a change in severity associated with any of the three Omicron descendent lineages BA.2.12.1, BA.4, and BA.5.
|
